Selga-M Tablet belongs to the class of 'antidiabetic drugs', primarily used to treat type 2 diabetes mellitus with a proper diet and exercise. Selga-M Tablet also lowers the risk of heart failure in type 2 diabetic patients with heart diseases. Diabetes mellitus is a metabolic disease that causes high blood sugar levels. It occurs when the insulin (a hormone produced by the beta cells of the pancreas) is resistant in breaking the glucose to produce energy (insulin resistance) or the pancreas (an organ behind the stomach) produce little or no insulin at all. Selga-M Tablet is not indicated for use in type 1 diabetes.

Selga-M Tablet is composed of two antidiabetic medicines, namely: Metformin and Dapagliflozin. Metformin belongs to the class of biguanides and manages blood sugar levels, particularly in obese patients. It exhibits a nonpancreatic effect to reduce blood glucose levels without increasing insulin secretion. Dapagliflozin belongs to the class of gliflozins. It works by reducing blood sugar levels by eliminating excess sugars from the body through urine.

Take Selga-M Tablet as advised by your doctor. Some common side effects of Selga-M Tablet include nausea, vomiting, diarrhoea, headache, weakness, runny nose, genital infection, dizziness, taste changes, and sore throat. Sometimes, Selga-M Tablet can cause side effects like lactic acidosis (a rare, but serious metabolic complication of excess lactic acid in the blood that is caused by metformin accumulation) and diabetic ketoacidosis (excess production of blood acids (ketones)). These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor. 

Selga-M Tablet may cause hypoglycaemia (low blood sugar); hence it advised to take healthy food with enough calories and avoid heavy exercises. Do not take or stop this medicine, if the doctor did not advise you to do so. Before starting Selga-M Tablet , let your doctor know if you have any medical history of heart, kidney or liver diseases, breathing problems, blood disorders, dehydration, alcohol use, low blood pressure, and yeast infection of genitals. It is advised to avoid your alcohol intake while using Selga-M Tablet to decrease the risk of lactic acidosis. Selga-M Tablet is not recommended for use during the second or third trimester of pregnancy and breastfeeding.

Selga-M Tablet treats type 2 diabetes mellitus and contains Metformin and Dapagliflozin. Metformin is a biguanide and manages blood sugar levels, particularly in obese patients. It exhibits a nonpancreatic effect to reduce blood glucose levels without increasing insulin secretion. It is also known as an insulin sensitizer as it increases the effects of insulin. Metformin is considered a unique antidiabetic drug since it does not cause hypoglycemia (lowered blood sugar levels). Dapagliflozin belongs to the class of gliflozins. It works by reducing blood sugar levels by eliminating excess sugars from the body through urine. Selga-M Tablet also reduces the risk of heart failure in patients with type 2 diabetes and heart disease. Selga-M Tablet may be advised with or without other medications along with diet and exercise to control blood sugar levels. 

Inform your doctor if you take other antidiabetic drugs so that the dosage of Selga-M Tablet will be adjusted accordingly. Do not abruptly stop taking Selga-M Tablet midway if the doctor did not advise you. Selga-M Tablet may cause hypoglycaemia (low blood sugar); hence it is advised to make healthy food with enough calories and avoid heavy exercises. Brief your medical history to doctor if you have any heart, kidney or liver diseases, breathing problems (asthma, obstructive lung diseases), blood problems like anaemia (lack of blood cells), vitamin B12 deficiency, pancreas problems/surgery, dehydration, alcohol use, low blood pressure, and yeast infection of genitals before taking Selga-M Tablet . Avoid alcohol intake while using Selga-M Tablet since it may increase the risk of lactic acidosis. Selga-M Tablet is not recommended for use during the second or third trimester of pregnancy and breastfeeding. Your doctor may advise alternate medications to control your diabetic condition in such cases. Selga-M Tablet is not recommended for people younger than 18 years of age.

• It is advised to monitor your blood sugar levels regularly.
• If you need to undergo any x-ray or CT scan using a dye that should be injected into your veins, your doctor may suggest you stop taking Selga-M Tablet temporarily.
• Regular monitoring of kidney functioning is advised while using Selga-M Tablet .
• Selga-M Tablet may make you test positive for a urine glucose test, hence inform your doctor in advance that you take Selga-M Tablet .